CETN2
Centrin-2
Also known as: CALT, CEN2, CETN2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P41208
- Gene
- CETN2
- Ensembl
- ENSG00000147400
- Chromosome
- X
- Canonical length
- 172 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Centrosome,Flagellar centriole,Mid piece,Principal piece
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Caltractin belongs to a family of calcium-binding proteins and is a structural component of the centrosome. The high level of conservation from algae to humans and its association with the centrosome suggested that caltractin plays a fundamental role in the structure and function of the microtubule-organizing center, possibly required for the proper duplication and segregation of the centrosome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
172 residues, UniProt reviewed canonical sequence.
>P41208|CETN2
1 MASNFKKANM ASSSQRKRMS PKPELTEEQK QEIREAFDLF DADGTGTIDV KELKVAMRAL
61 GFEPKKEEIK KMISEIDKEG TGKMNFGDFL TVMTQKMSEK DTKEEILKAF KLFDDDETGK
121 ISFKNLKRVA KELGENLTDE ELQEMIDEAD RDGDGEVSEQ EFLRIMKKTS LYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CETN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 234 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 234 nTPM
- fallopian tube: 229 nTPM
- epididymis: 110 nTPM
- hypothalamus: 88 nTPM
- kidney: 73 nTPM
- seminal vesicle: 73 nTPM
Single-cell type
- fallopian tube ciliated cells: 1,357 nCPM
- respiratory ciliated cells: 1,032 nCPM
- epididymal efferent duct ciliated cells: 1,014 nCPM
- endometrial ciliated cells: 661 nCPM
- epididymal principal cells: 233 nCPM
- esophageal apical cells: 174 nCPM
Immune cell
- eosinophil: 36 nTPM
- plasmacytoid DC: 20 nTPM
- basophil: 20 nTPM
- MAIT T-cell: 14 nTPM
- non-classical monocyte: 14 nTPM
- intermediate monocyte: 14 nTPM
Brain region
- choroid plexus: 92 nTPM
- midbrain: 61 nTPM
- medulla oblongata: 50 nTPM
- spinal cord: 43 nTPM
- white matter: 41 nTPM
- hypothalamus: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0.5
- gnomAD missense Z
- 1.5
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- centriole replication
- microtubule cytoskeleton organization
- mitotic cell cycle
- mRNA transport
- nucleotide-excision repair
- protein transport
- regulation of cytokinesis
- spermatogenesis
Molecular functions
- calcium ion binding
- G-protein beta/gamma-subunit complex binding
- heterotrimeric G-protein binding
- microtubule binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CETN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CETN2 as an antibody target. Whether an autoantibody or antibody against CETN2 could matter depends on whether native CETN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CETN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CETN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...